Aging
Navigate
Back to articleFigure 5(5 of 14)
100%
Figure 5
Figure 5.Correlation between CLCN4 expression and tumor immune molecules. Expression of CLCN4 in TISIDB in different tumor molecular subtypes. (A) ACC. (B) BRCA. (C) COAD. (D) ESCA. (E) HNSC. (F) KIRP. (G) LGG. (H) LUSC. (I) OV. (J) PCPG. (K) PRAD. (L) SKCM. (M) STAD. (N) UCEC.
Figure 5 — Comprehensive analysis and experimental validation reveal elevated CLCN4 is a promising biomarker in endometrial cancer | Aging